Portela-Gomes GM[au] - Search Results

Year	Number of Results
1984	3
1986	1
1987	2
1990	1
1995	1
1997	2
1999	2
2000	7
2001	1
2002	5
2003	2
2004	3
2005	1
2006	2
2007	2
2008	6
2009	1
2010	6
2022	0

1

Granins and granin-related peptides in neuroendocrine tumours.

Portela-Gomes GM, Grimelius L, Wilander E, Stridsberg M. Portela-Gomes GM, et al. Regul Pept. 2010 Nov 30;165(1):12-20. doi: 10.1016/j.regpep.2010.02.011. Epub 2010 Mar 6. Regul Pept. 2010. PMID: 20211659 Review.

2

Neuroendocrine cell markers for pancreatic islets and tumors.

Portela-Gomes GM, Hacker GW, Weitgasser R. Portela-Gomes GM, et al. Appl Immunohistochem Mol Morphol. 2004 Sep;12(3):183-92. doi: 10.1097/00129039-200409000-00001. Appl Immunohistochem Mol Morphol. 2004. PMID: 15551729 Review.

3

Chromogranin A immunoreactivity in neuroendocrine cells in the human gastrointestinal tract and pancreas.

Portela-Gomes GM. Portela-Gomes GM. Adv Exp Med Biol. 2000;482:193-203. doi: 10.1007/0-306-46837-9_15. Adv Exp Med Biol. 2000. PMID: 11192580 Review. No abstract available.

4

Immunohistochemical and biochemical studies with region-specific antibodies to chromogranins A and B and secretogranins II and III in neuroendocrine tumors.

Portela-Gomes GM, Grimelius L, Stridsberg M. Portela-Gomes GM, et al. Cell Mol Neurobiol. 2010 Nov;30(8):1147-53. doi: 10.1007/s10571-010-9585-x. Epub 2010 Nov 3. Cell Mol Neurobiol. 2010. PMID: 21046454 Review.

5

Malignant gastric ghrelinoma with hyperghrelinemia.

Tsolakis AV, Portela-Gomes GM, Stridsberg M, Grimelius L, Sundin A, Eriksson BK, Oberg KE, Janson ET. Tsolakis AV, et al. Among authors: portela gomes gm. J Clin Endocrinol Metab. 2004 Aug;89(8):3739-44. doi: 10.1210/jc.2003-032118. J Clin Endocrinol Metab. 2004. PMID: 15292299

6

Somatostatin receptor subtypes in human type 2 diabetic islets.

Portela-Gomes GM, Grimelius L, Westermark P, Stridsberg M. Portela-Gomes GM, et al. Pancreas. 2010 Aug;39(6):836-42. doi: 10.1097/MPA.0b013e3181cf1878. Pancreas. 2010. PMID: 20182388

7

Identification of complement C3 as an autoantigen in inflammatory bowel disease.

Lundgren BA, Rorsman F, Portela-Gomes GM, Grimelius L, Ekdahl KN, Nilsson B, Ekwall O. Lundgren BA, et al. Among authors: portela gomes gm. Eur J Gastroenterol Hepatol. 2010 Apr;22(4):429-36. doi: 10.1097/MEG.0b013e32833283b1. Eur J Gastroenterol Hepatol. 2010. PMID: 19829122

8

The importance of chromogranin A in the development and function of endocrine pancreas.

Portela-Gomes GM, Gayen JR, Grimelius L, Stridsberg M, Mahata SK. Portela-Gomes GM, et al. Regul Pept. 2008 Nov 29;151(1-3):19-25. doi: 10.1016/j.regpep.2008.07.005. Epub 2008 Aug 3. Regul Pept. 2008. PMID: 18722481

9

Immunoreactivity against Goblet cells in patients with inflammatory bowel disease.

Ardesjö B, Portela-Gomes GM, Rorsman F, Gerdin E, Lööf L, Grimelius L, Kämpe O, Ekwall O. Ardesjö B, et al. Among authors: portela gomes gm. Inflamm Bowel Dis. 2008 May;14(5):652-61. doi: 10.1002/ibd.20370. Inflamm Bowel Dis. 2008. PMID: 18213698

10

Immunohistochemical staining of human islet cells with region-specific antibodies against secretogranins II and III.

Stridsberg M, Grimelius L, Portela-Gomes GM. Stridsberg M, et al. Among authors: portela gomes gm. J Anat. 2008 Mar;212(3):229-34. doi: 10.1111/j.1469-7580.2008.00857.x. Epub 2008 Jan 25. J Anat. 2008. PMID: 18221483 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results